持続グルコースモニタリングシステム市場：コンポーネント、人口統計、患者タイプ、エンドユーザー、流通チャネル別-2025-2030年世界予測

持続グルコースモニタリングシステム市場の2023年の市場規模は55億4,000万米ドルで、2024年には62億1,000万米ドルに達すると予測され、2030年にはCAGR12.37％で125億5,000万米ドルに達すると予測されています。

持続グルコースモニタリング（CGM）システムは、糖尿病患者の間質液中のグルコースレベルを継続的に追跡するために使用される装置です。これらのシステムは通常、皮下に挿入する小型センサー、データを送信するトランスミッター、モニタリング用のレシーバーまたは互換性のあるスマートデバイスで構成されています。CGMの主な必要性は、リアルタイムのグルコース測定値を提供し、ユーザーにグルコースの変動を警告し、糖尿病の管理を容易にする能力に由来します。CGMの用途には、1型および2型糖尿病患者の血糖値を監視し、低血糖または高血糖を回避することが含まれます。最終用途の範囲は広く、ヘルスケア環境、外来患者環境、糖尿病管理および予防ケアのための在宅ケアを網羅しています。

CGMシステムの市場成長は、糖尿病有病率の増加、高度診断に対する認識と受容の高まり、予防ヘルスケアの重視の高まりが大きな原動力となっています。スマートデバイスやウェアラブルとの統合、センサーの精度や快適性の向上などの技術革新は、市場拡大の大きなチャンスとなります。企業は、機器の精度向上、コスト削減、ユーザーエクスペリエンス向上のための研究開発に投資することで、こうした機会を活用することができます。しかし、市場の成長は、高コスト、特定地域での保険償還の制限、規制上のハードルといった課題に直面しています。また、拡張性の問題や頻繁な校正の必要性も、普及を制限する要因となっています。

CGM市場は、特に非侵襲的モニタリングシステムの開拓、パーソナライズされた健康に関する洞察を得るためのデータ分析機能の強化、グルコース動向を予測するための人工知能の統合など、技術革新の機会を提供しています。デジタルヘルスプラットフォームのためのハイテク大手との提携も有益であろう。有望な市場であるにもかかわらず、市場には技術的な検証、より幅広いアクセスのための手頃な価格の問題への対処、慢性疾患管理を改善するための教育の重視が必要です。全体として、CGM技術の継続的な進歩とデジタルヘルスケアソリューションに対する好意的な政策は、市場を新たな次元に押し上げ、糖尿病患者の生活の質を向上させることができます。

市場力学：急速に進化する持続グルコースモニタリングシステム市場の主要市場インサイトを公開

持続グルコースモニタリングシステム市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 世界の糖尿病患者数の増加
  • CGMシステムに対する規制認可の増加
  • 在宅ヘルスケアにおけるCGMシステムの採用率の増加
• 市場抑制要因
  • 副作用の発生とCGMデバイスの精度の限界
• 市場機会
  • CGMシステムの技術的進歩と認知度の向上
  • 非侵襲的な方法への嗜好の高まりと潜在的な未診断患者数
• 市場の課題
  • 償還と厳しい規制の問題

ポーターの5つの力：持続グルコースモニタリングシステム市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：持続グルコースモニタリングシステム市場における外部からの影響の把握

外部マクロ環境要因は、持続グルコースモニタリングシステム市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析持続グルコースモニタリングシステム市場における競合情勢の把握

持続グルコースモニタリングシステム市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス持続グルコースモニタリングシステム市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、持続グルコースモニタリングシステム市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限はベンダーを明確かつ正確に区分し、ユーザーが戦略目標に最適なパートナーやソリューションを特定するのに役立ちます。

本レポートは、主要な注目分野を網羅した包括的な市場分析を提供しています：

1.市場の浸透度：業界主要企業の広範なデータを含む、現在の市場環境の詳細なレビュー。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界中で糖尿病患者の増加
    • CGMシステムの規制承認の増加
    • 在宅ヘルスケアにおけるCGMシステムの導入率の上昇
  • 抑制要因
    • CGM機器の副作用の発生と精度の限界
  • 機会
    • 技術の進歩とCGMシステムの認知度の高まり
    • 非侵襲的治療法への嗜好の高まりと潜在的な未診断患者層
  • 課題
    • 償還と厳格な規制の問題
• 市場セグメンテーション分析
  • コンポーネント：リアルタイム血糖モニタリング用 CGMシステムにおける送信機と受信機の利用率の向上
  • 人口統計：小児CGMシステムの継続的な進歩により、より効果的で侵襲性の低いものになる
  • 患者タイプ：1型糖尿病患者におけるCGMシステムの重要性の高まり。高精度、最小限の遅延時間、急激な血糖値の変化に対する予測アラートを実現
  • エンドユーザー：在宅患者によるリモートデータ共有機能を備えたCGMシステムの好感度が高まっている
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境
• 顧客のカスタマイズ

第6章 持続グルコースモニタリングシステム市場：コンポーネント別

• 統合インスリンポンプ
• センサー
• 送信機と受信機

第7章 持続グルコースモニタリングシステム市場人口統計別

• 成人人口
• 子供の人口

第8章 持続グルコースモニタリングシステム市場患者タイプ別

• 1型糖尿病
• 2型糖尿病

第9章 持続グルコースモニタリングシステム市場：エンドユーザー別

• 診断センターとクリニック
• 在宅ヘルスケア
• 集中治療室

第10章 持続グルコースモニタリングシステム市場：流通チャネル別

• 機関投資家向け販売
• 小売販売

第11章 南北アメリカの持続グルコースモニタリングシステム市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第12章 アジア太平洋地域の持続グルコースモニタリングシステム市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第13章 欧州・中東・アフリカの持続グルコースモニタリングシステム市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第14章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • シビオニクス、GS1持続血糖モニタリングシステムでCEマークを取得
  • デクスコムは、インスリンを使用していない糖尿病患者を対象とした新しいCGMでアメリカ人をターゲットにしている
  • 米国FDAがアボットのフリースタイルリブレ2およびフリースタイルリブレ3センサーを自動インスリン投与システムとの統合用に承認

企業一覧

• NXP Semiconductors N.V.
• Senseonics Holdings Inc.
• Nemaura Medical Inc.
• Sibionics
• Insulet Corporation
• Abbott Laboratories
• AgaMatrix Inc. by I-Sens Inc.
• Ascensia Diabetes Care Holdings AG
• Novo Nordisk A/S
• Ypsomed Holding AG
• STMicroelectronics N.V.
• Johnson & Johnson Services, Inc.
• Tandem Diabetes Care, Inc.
• F. Hoffmann-La Roche Ltd.
• A. Menarini Diagnostics s.r.l
• Dexcom, Inc.
• Medtrum Technologies Inc.
• Texas Instruments Incorporated
• Medtronic PLC

LIST OF FIGURES

• FIGURE 1. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET RESEARCH PROCESS
• FIGURE 2. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
• FIGURE 15. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 19. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 24. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 25. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET DYNAMICS
• TABLE 7. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY INTEGRATED INSULIN PUMPS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SENSORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TRANSMITTERS & RECEIVERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ADULT POPULATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CHILDREN POPULATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE 1 DIABETES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE 2 DIABETES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DIAGNOSTIC CENTERS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ICUS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY INSTITUTIONAL SALES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY RETAIL SALES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 30. ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 31. ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 32. ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 33. ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 34. ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 35. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 36. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 37. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 38. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 39. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 40. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 41. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 42. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 43. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 44. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 45. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 46. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 47. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 48. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 49. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 50. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 51. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 52. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 53. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 54. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 55. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 56. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 57. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 58. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 59. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 60. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 61. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 62. AUSTRALIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 63. AUSTRALIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 64. AUSTRALIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 65. AUSTRALIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 66. AUSTRALIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 67. CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 68. CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 69. CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 70. CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 71. CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 72. INDIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 73. INDIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 74. INDIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 75. INDIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 76. INDIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 77. INDONESIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 78. INDONESIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 79. INDONESIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 80. INDONESIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 81. INDONESIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 82. JAPAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 83. JAPAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 84. JAPAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 85. JAPAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 86. JAPAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 87. MALAYSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 88. MALAYSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 89. MALAYSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 90. MALAYSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 91. MALAYSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 92. PHILIPPINES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 93. PHILIPPINES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 94. PHILIPPINES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 95. PHILIPPINES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 96. PHILIPPINES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 97. SINGAPORE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 98. SINGAPORE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 99. SINGAPORE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 100. SINGAPORE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 101. SINGAPORE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 102. SOUTH KOREA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 103. SOUTH KOREA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 104. SOUTH KOREA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 105. SOUTH KOREA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 106. SOUTH KOREA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 107. TAIWAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 108. TAIWAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 109. TAIWAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 110. TAIWAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 111. TAIWAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 112. THAILAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 113. THAILAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 114. THAILAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 115. THAILAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 116. THAILAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 117. VIETNAM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 118. VIETNAM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 119. VIETNAM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 120. VIETNAM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 121. VIETNAM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 122. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 123. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 124. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 125. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 126. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 127. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 128. DENMARK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 129. DENMARK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 130. DENMARK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 131. DENMARK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 132. DENMARK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 133. EGYPT CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 134. EGYPT CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 135. EGYPT CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 136. EGYPT CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 137. EGYPT CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 138. FINLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 139. FINLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 140. FINLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 141. FINLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 142. FINLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 143. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 144. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 145. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 146. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 147. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 148. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 149. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 150. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 151. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 152. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 153. ISRAEL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 154. ISRAEL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 155. ISRAEL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 156. ISRAEL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 157. ISRAEL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 158. ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 159. ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 160. ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 161. ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 162. ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 163. NETHERLANDS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 164. NETHERLANDS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 165. NETHERLANDS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 166. NETHERLANDS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 167. NETHERLANDS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 168. NIGERIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 169. NIGERIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 170. NIGERIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 171. NIGERIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 172. NIGERIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 173. NORWAY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 174. NORWAY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 175. NORWAY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 176. NORWAY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 177. NORWAY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 178. POLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 179. POLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 180. POLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 181. POLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 182. POLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 183. QATAR CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 184. QATAR CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 185. QATAR CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 186. QATAR CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 187. QATAR CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 188. RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 189. RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 190. RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 191. RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 192. RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 193. SAUDI ARABIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 194. SAUDI ARABIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 195. SAUDI ARABIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 196. SAUDI ARABIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 197. SAUDI ARABIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 198. SOUTH AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 199. SOUTH AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 200. SOUTH AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 201. SOUTH AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 202. SOUTH AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 203. SPAIN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 204. SPAIN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 205. SPAIN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 206. SPAIN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 207. SPAIN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 208. SWEDEN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 209. SWEDEN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 210. SWEDEN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 211. SWEDEN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 212. SWEDEN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 213. SWITZERLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 214. SWITZERLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 215. SWITZERLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 216. SWITZERLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 217. SWITZERLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 218. TURKEY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 219. TURKEY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 220. TURKEY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 221. TURKEY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 222. TURKEY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 223. UNITED ARAB EMIRATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 224. UNITED ARAB EMIRATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 225. UNITED ARAB EMIRATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 226. UNITED ARAB EMIRATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 227. UNITED ARAB EMIRATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 228. UNITED KINGDOM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 229. UNITED KINGDOM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
• TABLE 230. UNITED KINGDOM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 231. UNITED KINGDOM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 232. UNITED KINGDOM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 233. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 234. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2023

The Continuous Glucose Monitoring Systems Market was valued at USD 5.54 billion in 2023, expected to reach USD 6.21 billion in 2024, and is projected to grow at a CAGR of 12.37%, to USD 12.55 billion by 2030.

Continuous Glucose Monitoring (CGM) systems are devices used to track glucose levels in the interstitial fluid of diabetes patients continuously. These systems typically consist of a small sensor inserted under the skin, a transmitter that sends data, and a receiver or a compatible smart device for monitoring. The primary necessity for CGM stems from its capability to provide real-time glucose readings, alert users about glucose fluctuations, and ease the management of diabetes. The applications of CGM include monitoring blood glucose levels in Type 1 and Type 2 diabetes patients to avoid hypoglycemic or hyperglycemic events. End-use scopes are wide, encompassing healthcare settings, outpatient settings, and home care for diabetes management and preventive care.

Market growth for CGM systems is significantly driven by the increasing prevalence of diabetes, rising awareness and acceptance of advanced diagnostics, and a growing emphasis on preventive healthcare. Technological innovations such as integration with smart devices and wearables, as well as improvements in sensor accuracy and comfort, present substantial opportunities for market expansion. Companies can capitalize on these opportunities by investing in R&D to enhance device accuracy, reduce costs, and improve user experience. However, market growth faces challenges like high costs, limited insurance reimbursement in certain regions, and regulatory hurdles. Scalability issues and the need for frequent calibration can also limit widespread adoption.

The CGM market presents opportunities for innovation, particularly in developing non-invasive monitoring systems, enhancing data analytics capabilities for personalized health insights, and integrating artificial intelligence to predict glucose trends. Partnerships with tech giants for digital health platforms could also be beneficial. Despite its promising landscape, the market requires navigating technical validation, addressing affordability issues for broader access, and emphasizing education to improve chronic disease management. Overall, continuous advancements in CGM technology and favorable policies towards digital healthcare solutions can propel the market into new dimensions, offering enhanced quality of life for diabetes patients.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Continuous Glucose Monitoring Systems Market

The Continuous Glucose Monitoring Systems Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing Number of Incidence of Diabetic Patients Globally
  • Growing Regulatory Approvals for the CGM Systems
  • Growing Adoption Rate of CGM Systems in Home Healthcare
• Market Restraints
  • Occurrence of Adverse Effects and Limited Accuracy of CGM Devices
• Market Opportunities
  • Technological Advancements and Increased Awareness of CGM Systems
  • Rising Preferences for Non-invasive Methods and Potential Undiagnosed Patient Population
• Market Challenges
  • Reimbursement and Stringent Regulatory Issues

Porter's Five Forces: A Strategic Tool for Navigating the Continuous Glucose Monitoring Systems Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Continuous Glucose Monitoring Systems Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Continuous Glucose Monitoring Systems Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Continuous Glucose Monitoring Systems Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Continuous Glucose Monitoring Systems Market

A detailed market share analysis in the Continuous Glucose Monitoring Systems Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Continuous Glucose Monitoring Systems Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Continuous Glucose Monitoring Systems Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Continuous Glucose Monitoring Systems Market, highlighting leading vendors and their innovative profiles. These include NXP Semiconductors N.V., Senseonics Holdings Inc., Nemaura Medical Inc., Sibionics, Insulet Corporation, Abbott Laboratories, AgaMatrix Inc. by I-Sens Inc., Ascensia Diabetes Care Holdings AG, Novo Nordisk A/S, Ypsomed Holding AG, STMicroelectronics N.V., Johnson & Johnson Services, Inc., Tandem Diabetes Care, Inc., F. Hoffmann-La Roche Ltd., A. Menarini Diagnostics s.r.l, Dexcom, Inc., Medtrum Technologies Inc., Texas Instruments Incorporated, and Medtronic PLC.

Market Segmentation & Coverage

This research report categorizes the Continuous Glucose Monitoring Systems Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Component, market is studied across Integrated Insulin Pumps, Sensors, and Transmitters & Receivers.
• Based on Demographics, market is studied across Adult Population and Children Population.
• Based on Patient Type, market is studied across Type 1 Diabetes and Type 2 Diabetes.
• Based on End User, market is studied across Diagnostic Centers & Clinics, Home Healthcare, and ICUs.
• Based on Distribution Channel, market is studied across Institutional Sales and Retail Sales.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing Number of Incidence of Diabetic Patients Globally
    • 5.1.1.2. Growing Regulatory Approvals for the CGM Systems
    • 5.1.1.3. Growing Adoption Rate of CGM Systems in Home Healthcare
  • 5.1.2. Restraints
    • 5.1.2.1. Occurrence of Adverse Effects and Limited Accuracy of CGM Devices
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological Advancements and Increased Awareness of CGM Systems
    • 5.1.3.2. Rising Preferences for Non-invasive Methods and Potential Undiagnosed Patient Population
  • 5.1.4. Challenges
    • 5.1.4.1. Reimbursement and Stringent Regulatory Issues
• 5.2. Market Segmentation Analysis
  • 5.2.1. Component: Increasing utilization of transmitters & receivers in CGM systems for real-time glucose monitoring
  • 5.2.2. Demographics: Ongoing advancements in children CGM systems to make it more effective and less invasive
  • 5.2.3. Patient Type: Rising significance of CGM system in Type 1 diabetes patient for high accuracy, minimal lag time, and predictive alerts for rapid glucose changes
  • 5.2.4. End User: Growing preference of CGM systems by home patients with remote data sharing capabilities
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental
• 5.5. Client Customization

6. Continuous Glucose Monitoring Systems Market, by Component

• 6.1. Introduction
• 6.2. Integrated Insulin Pumps
• 6.3. Sensors
• 6.4. Transmitters & Receivers

7. Continuous Glucose Monitoring Systems Market, by Demographics

• 7.1. Introduction
• 7.2. Adult Population
• 7.3. Children Population

8. Continuous Glucose Monitoring Systems Market, by Patient Type

• 8.1. Introduction
• 8.2. Type 1 Diabetes
• 8.3. Type 2 Diabetes

9. Continuous Glucose Monitoring Systems Market, by End User

• 9.1. Introduction
• 9.2. Diagnostic Centers & Clinics
• 9.3. Home Healthcare
• 9.4. ICUs

10. Continuous Glucose Monitoring Systems Market, by Distribution Channel

• 10.1. Introduction
• 10.2. Institutional Sales
• 10.3. Retail Sales

11. Americas Continuous Glucose Monitoring Systems Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Continuous Glucose Monitoring Systems Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Continuous Glucose Monitoring Systems Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2023
• 14.2. FPNV Positioning Matrix, 2023
• 14.3. Competitive Scenario Analysis
  • 14.3.1. Sibionics obtains CE Mark for GS1 continuous glucose monitoring system
  • 14.3.2. Dexcom targets Americans with new CGM aimed at non-insulin-using diabetics
  • 14.3.3. U.S. FDA Clears Abbott's Freestyle Libre 2 and Freestyle Libre 3 Sensors for Integration with Automated Insulin Delivery Systems

Companies Mentioned

• 1. NXP Semiconductors N.V.
• 2. Senseonics Holdings Inc.
• 3. Nemaura Medical Inc.
• 4. Sibionics
• 5. Insulet Corporation
• 6. Abbott Laboratories
• 7. AgaMatrix Inc. by I-Sens Inc.
• 8. Ascensia Diabetes Care Holdings AG
• 9. Novo Nordisk A/S
• 10. Ypsomed Holding AG
• 11. STMicroelectronics N.V.
• 12. Johnson & Johnson Services, Inc.
• 13. Tandem Diabetes Care, Inc.
• 14. F. Hoffmann-La Roche Ltd.
• 15. A. Menarini Diagnostics s.r.l
• 16. Dexcom, Inc.
• 17. Medtrum Technologies Inc.
• 18. Texas Instruments Incorporated
• 19. Medtronic PLC